![](https://endpts.com/wp-content/uploads/2021/07/Francis-deSouza-Getty-1-scaled.jpg)
Illumina president and CEO Francis deSouza (Photo by Kevin Dietsch/Getty Images)
EU set to launch full-scale investigation into Grail-Illumina deal amid antitrust concerns — report
The proposed $8 billion merger between liquid biopsy firm Grail and cancer blood screening giant Illumina has met with nothing but flack since it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.